A Review of SARS-CoV-2 Genetic and Structure: Hot Cellular Targets for Virus Entry Genetic and structure of COVID-19
Archives of Medical Laboratory Sciences,
Vol. 7 (2021),
13 March 2021
,
Page 1-9 (e15)
https://doi.org/10.22037/amls.v7.34216
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses several molecules such as angiotensin-converting enzyme 2 (ACE2), cluster of differentiation 26 (CD26), Ezrin, and Neuropilin-1 (NRP-1) for viral entry. In this review, the entire structural and genomic combination and the mechanism of virus entry, are discussed. This study might be useful for further drug design studies. SARS-CoV-2 neutralization allows the immune system to fight the virus before its entry. COVID-19 enters the host bloodstream by infecting endothelial cells via a cluster of differentiation 147 (CD147). SARS-CoV-2 not only uses ACE2 for its entry but also affects ACE-2 and its enzymatic activity on Ang II and bradykinin, it also imbalances the RAAS and bradykinin system and elevates the inflammation. High levels of bradykinin, cause nonproductive cough as the result of fluid extravasation and leukocyte recruitment to the lung. Accordingly, we suggest replicase transcriptase complex (RTC) and specific non-structural proteins (Nsps) such as Nsp7,8, Nsp10, Nsp12, and Nsp16 are perfect targets of study because RTC and Nsps are the golden elements in the maintenance of COVID-19 appearance and masking. Base on this evidence COVID-19 uses various receptors for its entry and it might block these receptors' activity to evade the immune system and spread to other cells.
*Corresponding Authors: Elham Rajaei, Email: elhamrj@gmail.com; ORCID: https://orcid.org/0000-0002-8231-0138
Please cite this article as: Torabizadeh M, Ghobadi Dana V, Aghapour SA, Zibara K, Deris Zayeri Z, Rajaei E. A Review of SARS-CoV-2 Genetic and Structure: Hot Cellular Targets for Virus Entry. Arch Med Lab Sci. 2021;7:1-9 (e15). https://doi.org/10.22037/amls.v7.34216
- COVID-19
- SARS-CoV-2
- Genetic
- Structure
- Non-Structural Proteins
- Angiotensin-Converting Enzyme 2
How to Cite
References
Brücher BL, Nigri G, Tinelli A, Lapeña JFF, Espin-Basany E, Macri P, et al. COVID-19: Pandemic surgery guidance. 4open. 2020;3:1.
Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S, et al. Detection of Covid-19 in children in early January 2020 in Wuhan, China. New England Journal of Medicine. 2020;382(14):1370-1.
Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020:1-8.
Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients. Clinical Infectious Diseases. 2020; 28;71(15):713-720.
Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections. 2020;9(1):221-36.
Dabravolski SA, Kavalionak YK. SARS‐CoV‐2: Spike glycoprotein structural diversity, phylogeny and potential animal host identification. Journal of Medical Virology. 2020; 92(9):1690-1694.
Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: A promising cure for the global panic. Science of the Total Environment. 2020:138277.
Manhas S, Anjali A, Mansoor S, Sharma V, Ahmad A, Rehman MU, et al. Covid-19 Pandemic and Current Medical Interventions. Archives of Medical Research. 2020; 51(6):473-481.
Jeena LM, Singh N, Tempe A. Molecular Mechanism of Coronaviruses (COVID-19) and Diagnostic Approaches: A Systematic Review. AIJR Preprints. 2020; 5,21
Cortey M, Li Y, Díaz I, Clilverd H, Darwich L, Mateu E. SARS-CoV-2 amino acid substitutions widely spread in the human population are mainly located in highly conserved segments of the structural proteins. bioRxiv. 2020; 6,1
Mosaddeghi P, Negahdaripour M, Dehghani Z, Farahmandnejad M, Moghadami M, Nezafat N, et al. Therapeutic approaches for COVID-19 based on the dynamics of interferon-mediated immune responses. 2020;16: 1
Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, et al. Clinical, molecular and epidemiological characterization of the SARS-CoV2 virus and the Coronavirus disease 2019 (COVID-19), a comprehensive literature review. Diagnostic Microbiology and Infectious Disease. 2020; ;98(1):115094.
Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Frontiers in Immunology. 2020;11:827.
Yoshimoto FK. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19. The Protein Journal. 2020; 39(3):198-216.
Koyama T, Platt D, Parida L. Variant analysis of COVID-19 genomes. Bulletin of the World Health Organization. 2020. 98(7).
Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses; Methods Mol Biol, 2015;1282:1-23.
Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, Hirschenberger M, et al. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. bioRxiv. 2020.
Abdul Kadhim A, Hadi N, Abdulhussein M. Preprocessing of the Candidate Antiviral Drugs against COVID-19 in Models of SARS cov2 Targets. Prensa Med Argent. 2020;106:2.
Ng YL. Functional studies of viral and host cell factors involved in the regulation of coronavirus replication and pathogenesis. A thesis submitted to the Nanyang Technological University, 2019.
Ibrahim IM, Abdelmalek DH, Elshahat ME, Elfiky AA. COVID-19 spike-host cell receptor GRP78 binding site prediction. Journal of Infection. 2020; 80(5):554-562.
Shannon A, Le NTT, Selisko B, Eydoux C, Alvarez K, Guillemot J-C, et al. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. Antiviral Research. 2020:104793.
Zúñiga Lucas S, Pascual-Iglesias A, Sánchez CM, Solá Gurpegui I, Enjuanes Sánchez L. Virulence factors in porcine coronaviruses and vaccine design. 2016, V. 226, 142-151
Moustaqil M, Ollivier E, Chiu H-P, Rudolffi-Soto P, Van Tol S, Stevens C, et al. SARS-CoV-2 proteases cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species and the search for reservoir hosts. bioRxiv. 2020.
Sawicki SG, Sawicki DL, Siddell SG. A contemporary view of coronavirus transcription. Journal of virology. 2007;81(1):20-9.
Karikalan B, Darnal HK. Immune Status of COVID-19 patients with reference to SARS and MERS. J Pure Appl Microbiol. 2020;14.
Yin C. Genotyping coronavirus SARS-CoV-2: methods and implications. Genomics. 2020.
Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C. Antiviral activities of type I interferons to SARS-CoV-2 infection. Antiviral research. 2020:104811.
Te Velthuis AJ, van den Worm SH, Snijder EJ. The SARS-coronavirus nsp7+ nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension. Nucleic acids research. 2012;40(4):1737-47.
Chang Y-C, Tung Y-A, Lee K-H, Chen T-F, Hsiao Y-C, Chang H-C, et al. Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking. 2020. v2.242.
Shu T, Huang M, Wu D, Ren Y, Zhang X, Han Y, et al. SARS-coronavirus-2 nsp13 possesses NTPase and RNA helicase activities. 2020;35(3): 321–329
Hoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Molecular Cell. 2020; 21;78(4):779-784.e5.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 16;181(2):271-280.e8.
Kihira S, Schefflein J, Chung M, Mahmoudi K, Rigney B, Delman BN, et al. Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic. Journal of NeuroInterventional Surgery. 2020;12(7):669-72.
Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, et al. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. American journal of respiratory and critical care medicine. 2005;171(8):850-7.
Reguera J, Mudgal G, Santiago C, Casasnovas JM. A structural view of coronavirus–receptor interactions. Virus research. 2014;194:3-15.
Ziegler C, Allon SJ, Nyquist SK, Mbano I, Miao VN, Cao Y, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is enriched in specific cell subsets across tissues. 2020; 28;181(5):1016-1035.e19.
Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112-6.
Hulswit R, de Haan C, Bosch B-J. Coronavirus spike protein and tropism changes. Advances in virus research. 96: Elsevier; 2016. p. 29-57.
Joyce MG, Sankhala RS, Chen W-H, Choe M, Bai H, Hajduczki A, et al. A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein. bioRxiv. 2020.03.15.992883.
Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020; 81(2):281-292.e6.
Paoloni-Giacobino A, Chen H, Peitsch MC, Rossier C, Antonarakis SE. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22. 3. Genomics. 1997;44(3):309-20.
Bertram S, Glowacka I, Blazejewska P, Soilleux E, Allen P, Danisch S, et al. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. Journal of virology. 2010;84(19):10016-25.
Bertram S, Glowacka I, Müller MA, Lavender H, Gnirss K, Nehlmeier I, et al. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. Journal of virology. 2011;85(24):13363-72.
Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher T. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. Journal of virology. 2011;85(2):873-82.
Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proceedings of the National Academy of Sciences. 2020;117(13):7001-3.
Glowacka I, Bertram S, Müller MA, Allen P, Soilleux E, Pfefferle S, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of virology. 2011;85(9):4122-34.
Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Chemistry. 2000;275(43):33238-43.
Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI, et al. Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). Journal of Biological Chemistry. 2005;280(34):30113-9.
Guo L, Niu J, Yu H, Gu W, Li R, Luo X, et al. Modulation of CD163 expression by metalloprotease ADAM17 regulates porcine reproductive and respiratory syndrome virus entry. Journal of virology. 2014;88(18):10448-58.
Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pöhlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. Journal of virology. 2014;88(2):1293-307.
DeBerge MP, Ely KH, Cheng G-S, Enelow RI. ADAM17-mediated processing of TNF-α expressed by antiviral effector CD8+ T cells is required for severe T-cell-mediated lung injury. PloS one. 2013;8(11).
Hirano T, Murakami M. COVID-19: A new virus, but a familiar receptor and cytokine release syndrome. Immunity. 2020; 52(5):731-733.
Palau V, Riera M, Soler MJ. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrology Dialysis Transplantation. 2020; 35(6):1071-1072.
van Veenendaal LM, Bertolli E, Korse CM, Klop WMC, Tesselaar MET, van Akkooi ACJ. The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC). Annals of Surgical Oncology. 2020; 28 (2):1019-1028.
Iacono KT, Brown AL, Greene MI, Saouaf SJ. CD147 immunoglobulin superfamily receptor function and role in pathology. Experimental and molecular pathology. 2007;83(3):283-95.
Koch C, Staffler G, Hüttinger R, Hilgert I, Prager E, Černý J, et al. T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density. International immunology. 1999;11(5):777-86.
Yurchenko V, Constant S, Eisenmesser E, Bukrinsky M. Cyclophilin–CD147 interactions: a new target for anti‐inflammatory therapeutics. Clinical & Experimental Immunology. 2010;160(3):305-17.
Fleischer B. CD26: a surface protease involved in T-cell activation. Immunology today. 1994;15(4):180-4.
Simeoni L, Rufini A, Moretti T, Forte P, Aiuti A, Fantoni A. Human CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution. Human immunology. 2002;63(9):719-30.
De Meester I, Korom S, Van Damme J, Scharpé S. CD26, let it cut or cut it down. Immunology today. 1999;20(8):367-75.
Vankadari N, Wilce JA. Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerging microbes & infections. 2020;9(1):601-4.
Sargiacomo C, Sotgia F, Lisanti MP. COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? Aging (Albany NY). 2020;12(8):6511.
Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nature medicine. 2004;10(2):175-81.
Fievet BT, Gautreau A, Roy C, Del Maestro L, Mangeat P, Louvard D, et al. Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin. The Journal of cell biology. 2004;164(5):653-9.
Lundstrom K. Coronavirus Pandemic—Therapy and Vaccines. Biomedicines. 2020;8(5):109.
Patel CN, Chirag N, Pandya D, Himanshu A, Rawal D, Rakesh M. Identification of Potential Binders of the SARS-Cov-2 Spike Protein via Molecular Docking, Dynamics Simulation and Binding Free Energy Calculation. 2020; 181) 5( :1016-1035.e19
Segars J, Katler Q, McQueen DB, Kotlyar A, Glenn T, Knight Z, et al. Prior and novel coronaviruses, COVID-19, and human reproduction: what is known? Fertility and Sterility. 2020; 113(6):1140-1149
- Abstract Viewed: 113 times
- PDF Downloaded: 81 times